Open access · US-GOV
via ClinicalTrials.gov Clinical trial
COcoa Supplement and Multivitamin Outcomes Study-Mind
Authors not listed
Wake Forest University Health Sciences · 2016
Abstract
The parent trial (COcoa Supplement and Multivitamin Outcomes Study, COSMOS; NCT02422745) is a randomized clinical trial of cocoa extract supplement (containing a total of 500 mg/d flavanols, including 80 mg. (-)-epicatechins), and a standard multivitamin supplement to reduce the risk of cardiovascular disease and cancer among men aged 60 years and older and women aged 65 years and older. A cognitive ancillary study (COSMOS-Mind) is being conducted among men and women, 65 years and older, who are enrolled in COSMOS and will examine whether the cocoa extract supplement or the multivitamin supplement improves cognitive function and reduces risk of cognitive impairment, including Alzheimer's disease (AD) and other related types of dementia. Participants at the Wake Forest site will only be getting a phone call.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-07-02 MST
Cite this
APA
Anonymous. (2016). COcoa Supplement and Multivitamin Outcomes Study-Mind. <em>Wake Forest University Health Sciences</em>. https://clinicaltrials.gov/study/NCT03035201
Vancouver
Anonymous. COcoa Supplement and Multivitamin Outcomes Study-Mind. Wake Forest University Health Sciences. 2016.
BibTeX
@misc{anon2016COcoaS,
title = {COcoa Supplement and Multivitamin Outcomes Study-Mind},
author = {Anonymous},
journal = {Wake Forest University Health Sciences},
year = {2016},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Steven E Arnold, MD 2020
Open access · US-GOV
A Crossover, Randomized Block Sequence, Double-Blind, Placebo-Controlled Trial for Nicotinamide Riboside in Subjective Cognitive Decline and Mild Cognitive Impairment in Aging
Scale Media Inc 2024
Open access · US-GOV
A Clinical Trial to Investigate the Efficacy of a Supplement to Improve and Maintain Cognitive Function and Memory
Drexel University 2021
Open access · US-GOV
Effects of a 24-week Remote-based Resistance Training Program on Parameters of the Metabolic Syndrome, Cognitive Function, and Quality of Life in Older Adults Living With Mild Cognitive Impairment and Alzheimer's Disease and/or a Related Dementia
Journal of the European Academy of Dermatology and Venereology 2022
Preprint · OA
The link between cutaneous inflammation and cognitive impairment
JAMA 1997
Citation only
Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease
Alzheimer s & Dementia 2011
Open access · OA